Article Details
Retrieved on: 2020-11-24 16:23:12
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The alternate care site has been provided with 1,000 doses of bamlanivimab, a <b>monoclonal antibody</b> therapy created by Eli Lilly & Company that was ...
Article found on: kvia.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here